Breaking News, Promotions & Moves

Curia Taps Steve Lavezoli as VP of Biologics

Lavezoli to lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.

Author Image

By: Charlie Sternberg

Associate Editor

Curia, a contract research, development and manufacturing organization, has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.   Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.   “This is an exciting time for our biologics team, and we are pleased to have Steve on board,” said Curia CEO Philip Macnabb. “Steve’s remarkable breadth of experience leading commercial operations for biologics development and m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters